Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-30

Clinical Trial Update: Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing NOMAC-E2 combined oral contraceptive to LNG-EE, evaluating effects on hemostasis, lipids, carbohydrate metabolism, adrenal and thyroid f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LNG/EE (levonorgestrel/ethinyl estradiol)
  • NOMAC-E2 (nomegestrol acetate / 17β-estradiol)

Snippet

Sponsor: Organon and Co | Conditions: Contraception | Phase 3 | Status: COMPLETED | Results posted: 2011-08-30